Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Finished Goods (2018 - 2022)

AVITA Medical (RCEL) has disclosed Finished Goods for 1 consecutive years, with $610000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Finished Goods changed N/A year-over-year to $610000.0, compared with a TTM value of $610000.0 through Dec 2022, changed N/A, and an annual FY2022 reading of $610000.0, changed N/A over the prior year.
  • Finished Goods was $610000.0 for Q4 2022 at AVITA Medical.
  • Across five years, Finished Goods topped out at $610000.0 in Q4 2022 and bottomed at $610000.0 in Q4 2022.